Pharmacogenomics (Pharmacogenomics)

Publisher : Taylor & Francis

impact on R&D and regulatory strategies emerging technologies exploiting genomic information

Claim Your Journal Get PRC Visit Website

e-ISSN 1744-8042

p-ISSN 1462-2416

Issue Frequency Monthly

Impact Factor 1.9

Est. Year 2000

Mobile 4402080520500

DOI YES

Language English

APC YES

Impact Factor Assignee GOOGLE SCHOLAR

Email enquiries@taylorandfrancis.com

Journal Descriptions

Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this rapdly developing field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community including: the emegence of new pharmacogenomics initiatives and their impact on R&D and regulatory strategies; emerging technologies for accessing and exploiting genomic information; reviews of genotyping and clinical data in particular therapeutic areas; development of novel diagnostic products and strategies. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.

Pharmacogenomics (Pharmacogenomics) is :-

International, Peer-Reviewed, Open Access, Refereed, impact on R&D and regulatory strategies, emerging technologies, exploiting genomic information, reviews of genotyping, clinical data in particular therapeutic areas, development of novel diagnostic products and strategies , Online or Print , Monthly Journal
UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1462-2416, E-ISSN: 1744-8042, Established: 2000, Impact Factor: 1.9
Provides Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE